Chemical & Material
Global Pharmaceutical API and Intermediates Market Research Report 2025
- May 05, 25
- ID: 225498
- Pages: 124
- Figures: 118
- Views: 12
The global market for Pharmaceutical API and Intermediates was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pharmaceutical intermediates are also called organic pharmaceutical intermediates, which refer to a semi-finished product and are a product in the production of certain products. The raw material drug refers to the active ingredient of the drug and is also the basic substance that constitutes the pharmacological effect of the drug. API is a pharmaceutical active substance prepared through chemical synthesis, plant extraction or biotechnology.
The market for pharmaceutical raw materials and intermediates has always been a vital part of the global pharmaceutical industry. APIs are key ingredients in the pharmaceutical process, while intermediates are chemicals required in the intermediate production stages of APIs. The current status of these two markets is affected by multiple factors, including global medical needs, innovative drug development, regulations and policies, pharmaceutical company competition, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical API and Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical API and Intermediates.
The Pharmaceutical API and Intermediates market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical API and Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical API and Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Patheon
Jubilant
BASF
Lianhetech
ABA Chem
Granules India
Porton
Actylis
Pfizer
CordenPharma
Codexis
Sanofi
Chiracon
Jiuzhou Pharmaceutical
Stanley
Menohua
Tianyu shares
Puluo Pharmaceutical
Huahai Pharmaceutical
by Type
API
Pharmaceutical Intermediates
by Application
Pharmaceutical
Health Products
Feed
Food
Cosmetics
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical API and Intermediates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical API and Intermediates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical API and Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Pharmaceutical intermediates are also called organic pharmaceutical intermediates, which refer to a semi-finished product and are a product in the production of certain products. The raw material drug refers to the active ingredient of the drug and is also the basic substance that constitutes the pharmacological effect of the drug. API is a pharmaceutical active substance prepared through chemical synthesis, plant extraction or biotechnology.
The market for pharmaceutical raw materials and intermediates has always been a vital part of the global pharmaceutical industry. APIs are key ingredients in the pharmaceutical process, while intermediates are chemicals required in the intermediate production stages of APIs. The current status of these two markets is affected by multiple factors, including global medical needs, innovative drug development, regulations and policies, pharmaceutical company competition, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical API and Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical API and Intermediates.
The Pharmaceutical API and Intermediates market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical API and Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical API and Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Patheon
Jubilant
BASF
Lianhetech
ABA Chem
Granules India
Porton
Actylis
Pfizer
CordenPharma
Codexis
Sanofi
Chiracon
Jiuzhou Pharmaceutical
Stanley
Menohua
Tianyu shares
Puluo Pharmaceutical
Huahai Pharmaceutical
by Type
API
Pharmaceutical Intermediates
by Application
Pharmaceutical
Health Products
Feed
Food
Cosmetics
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical API and Intermediates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical API and Intermediates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical API and Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
1 Pharmaceutical API and Intermediates Market Overview
1.1 Product Definition
1.2 Pharmaceutical API and Intermediates by Type
1.2.1 Global Pharmaceutical API and Intermediates Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 API
1.2.3 Pharmaceutical Intermediates
1.3 Pharmaceutical API and Intermediates by Application
1.3.1 Global Pharmaceutical API and Intermediates Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Health Products
1.3.4 Feed
1.3.5 Food
1.3.6 Cosmetics
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pharmaceutical API and Intermediates Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pharmaceutical API and Intermediates Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pharmaceutical API and Intermediates Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical API and Intermediates Production Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical API and Intermediates Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pharmaceutical API and Intermediates, Industry Ranking, 2023 VS 2024
2.4 Global Pharmaceutical API and Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical API and Intermediates Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pharmaceutical API and Intermediates, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical API and Intermediates, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical API and Intermediates, Date of Enter into This Industry
2.9 Pharmaceutical API and Intermediates Market Competitive Situation and Trends
2.9.1 Pharmaceutical API and Intermediates Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical API and Intermediates Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical API and Intermediates Production by Region
3.1 Global Pharmaceutical API and Intermediates Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pharmaceutical API and Intermediates Production Value by Region (2020-2031)
3.2.1 Global Pharmaceutical API and Intermediates Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pharmaceutical API and Intermediates by Region (2026-2031)
3.3 Global Pharmaceutical API and Intermediates Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pharmaceutical API and Intermediates Production Volume by Region (2020-2031)
3.4.1 Global Pharmaceutical API and Intermediates Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pharmaceutical API and Intermediates by Region (2026-2031)
3.5 Global Pharmaceutical API and Intermediates Market Price Analysis by Region (2020-2025)
3.6 Global Pharmaceutical API and Intermediates Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
4 Pharmaceutical API and Intermediates Consumption by Region
4.1 Global Pharmaceutical API and Intermediates Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pharmaceutical API and Intermediates Consumption by Region (2020-2031)
4.2.1 Global Pharmaceutical API and Intermediates Consumption by Region (2020-2025)
4.2.2 Global Pharmaceutical API and Intermediates Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical API and Intermediates Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pharmaceutical API and Intermediates Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical API and Intermediates Production by Type (2020-2031)
5.1.1 Global Pharmaceutical API and Intermediates Production by Type (2020-2025)
5.1.2 Global Pharmaceutical API and Intermediates Production by Type (2026-2031)
5.1.3 Global Pharmaceutical API and Intermediates Production Market Share by Type (2020-2031)
5.2 Global Pharmaceutical API and Intermediates Production Value by Type (2020-2031)
5.2.1 Global Pharmaceutical API and Intermediates Production Value by Type (2020-2025)
5.2.2 Global Pharmaceutical API and Intermediates Production Value by Type (2026-2031)
5.2.3 Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2020-2031)
5.3 Global Pharmaceutical API and Intermediates Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pharmaceutical API and Intermediates Production by Application (2020-2031)
6.1.1 Global Pharmaceutical API and Intermediates Production by Application (2020-2025)
6.1.2 Global Pharmaceutical API and Intermediates Production by Application (2026-2031)
6.1.3 Global Pharmaceutical API and Intermediates Production Market Share by Application (2020-2031)
6.2 Global Pharmaceutical API and Intermediates Production Value by Application (2020-2031)
6.2.1 Global Pharmaceutical API and Intermediates Production Value by Application (2020-2025)
6.2.2 Global Pharmaceutical API and Intermediates Production Value by Application (2026-2031)
6.2.3 Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2020-2031)
6.3 Global Pharmaceutical API and Intermediates Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Lonza
7.1.1 Lonza Pharmaceutical API and Intermediates Company Information
7.1.2 Lonza Pharmaceutical API and Intermediates Product Portfolio
7.1.3 Lonza Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Lonza Main Business and Markets Served
7.1.5 Lonza Recent Developments/Updates
7.2 Catalent
7.2.1 Catalent Pharmaceutical API and Intermediates Company Information
7.2.2 Catalent Pharmaceutical API and Intermediates Product Portfolio
7.2.3 Catalent Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Catalent Main Business and Markets Served
7.2.5 Catalent Recent Developments/Updates
7.3 Patheon
7.3.1 Patheon Pharmaceutical API and Intermediates Company Information
7.3.2 Patheon Pharmaceutical API and Intermediates Product Portfolio
7.3.3 Patheon Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Patheon Main Business and Markets Served
7.3.5 Patheon Recent Developments/Updates
7.4 Jubilant
7.4.1 Jubilant Pharmaceutical API and Intermediates Company Information
7.4.2 Jubilant Pharmaceutical API and Intermediates Product Portfolio
7.4.3 Jubilant Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Jubilant Main Business and Markets Served
7.4.5 Jubilant Recent Developments/Updates
7.5 BASF
7.5.1 BASF Pharmaceutical API and Intermediates Company Information
7.5.2 BASF Pharmaceutical API and Intermediates Product Portfolio
7.5.3 BASF Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.5.4 BASF Main Business and Markets Served
7.5.5 BASF Recent Developments/Updates
7.6 Lianhetech
7.6.1 Lianhetech Pharmaceutical API and Intermediates Company Information
7.6.2 Lianhetech Pharmaceutical API and Intermediates Product Portfolio
7.6.3 Lianhetech Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Lianhetech Main Business and Markets Served
7.6.5 Lianhetech Recent Developments/Updates
7.7 ABA Chem
7.7.1 ABA Chem Pharmaceutical API and Intermediates Company Information
7.7.2 ABA Chem Pharmaceutical API and Intermediates Product Portfolio
7.7.3 ABA Chem Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.7.4 ABA Chem Main Business and Markets Served
7.7.5 ABA Chem Recent Developments/Updates
7.8 Granules India
7.8.1 Granules India Pharmaceutical API and Intermediates Company Information
7.8.2 Granules India Pharmaceutical API and Intermediates Product Portfolio
7.8.3 Granules India Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Granules India Main Business and Markets Served
7.8.5 Granules India Recent Developments/Updates
7.9 Porton
7.9.1 Porton Pharmaceutical API and Intermediates Company Information
7.9.2 Porton Pharmaceutical API and Intermediates Product Portfolio
7.9.3 Porton Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Porton Main Business and Markets Served
7.9.5 Porton Recent Developments/Updates
7.10 Actylis
7.10.1 Actylis Pharmaceutical API and Intermediates Company Information
7.10.2 Actylis Pharmaceutical API and Intermediates Product Portfolio
7.10.3 Actylis Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Actylis Main Business and Markets Served
7.10.5 Actylis Recent Developments/Updates
7.11 Pfizer
7.11.1 Pfizer Pharmaceutical API and Intermediates Company Information
7.11.2 Pfizer Pharmaceutical API and Intermediates Product Portfolio
7.11.3 Pfizer Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Pfizer Main Business and Markets Served
7.11.5 Pfizer Recent Developments/Updates
7.12 CordenPharma
7.12.1 CordenPharma Pharmaceutical API and Intermediates Company Information
7.12.2 CordenPharma Pharmaceutical API and Intermediates Product Portfolio
7.12.3 CordenPharma Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.12.4 CordenPharma Main Business and Markets Served
7.12.5 CordenPharma Recent Developments/Updates
7.13 Codexis
7.13.1 Codexis Pharmaceutical API and Intermediates Company Information
7.13.2 Codexis Pharmaceutical API and Intermediates Product Portfolio
7.13.3 Codexis Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Codexis Main Business and Markets Served
7.13.5 Codexis Recent Developments/Updates
7.14 Sanofi
7.14.1 Sanofi Pharmaceutical API and Intermediates Company Information
7.14.2 Sanofi Pharmaceutical API and Intermediates Product Portfolio
7.14.3 Sanofi Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Sanofi Main Business and Markets Served
7.14.5 Sanofi Recent Developments/Updates
7.15 Chiracon
7.15.1 Chiracon Pharmaceutical API and Intermediates Company Information
7.15.2 Chiracon Pharmaceutical API and Intermediates Product Portfolio
7.15.3 Chiracon Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Chiracon Main Business and Markets Served
7.15.5 Chiracon Recent Developments/Updates
7.16 Jiuzhou Pharmaceutical
7.16.1 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Company Information
7.16.2 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
7.16.3 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Jiuzhou Pharmaceutical Main Business and Markets Served
7.16.5 Jiuzhou Pharmaceutical Recent Developments/Updates
7.17 Stanley
7.17.1 Stanley Pharmaceutical API and Intermediates Company Information
7.17.2 Stanley Pharmaceutical API and Intermediates Product Portfolio
7.17.3 Stanley Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Stanley Main Business and Markets Served
7.17.5 Stanley Recent Developments/Updates
7.18 Menohua
7.18.1 Menohua Pharmaceutical API and Intermediates Company Information
7.18.2 Menohua Pharmaceutical API and Intermediates Product Portfolio
7.18.3 Menohua Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Menohua Main Business and Markets Served
7.18.5 Menohua Recent Developments/Updates
7.19 Tianyu shares
7.19.1 Tianyu shares Pharmaceutical API and Intermediates Company Information
7.19.2 Tianyu shares Pharmaceutical API and Intermediates Product Portfolio
7.19.3 Tianyu shares Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.19.4 Tianyu shares Main Business and Markets Served
7.19.5 Tianyu shares Recent Developments/Updates
7.20 Puluo Pharmaceutical
7.20.1 Puluo Pharmaceutical Pharmaceutical API and Intermediates Company Information
7.20.2 Puluo Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
7.20.3 Puluo Pharmaceutical Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.20.4 Puluo Pharmaceutical Main Business and Markets Served
7.20.5 Puluo Pharmaceutical Recent Developments/Updates
7.21 Huahai Pharmaceutical
7.21.1 Huahai Pharmaceutical Pharmaceutical API and Intermediates Company Information
7.21.2 Huahai Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
7.21.3 Huahai Pharmaceutical Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.21.4 Huahai Pharmaceutical Main Business and Markets Served
7.21.5 Huahai Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical API and Intermediates Industry Chain Analysis
8.2 Pharmaceutical API and Intermediates Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical API and Intermediates Production Mode & Process Analysis
8.4 Pharmaceutical API and Intermediates Sales and Marketing
8.4.1 Pharmaceutical API and Intermediates Sales Channels
8.4.2 Pharmaceutical API and Intermediates Distributors
8.5 Pharmaceutical API and Intermediates Customer Analysis
9 Pharmaceutical API and Intermediates Market Dynamics
9.1 Pharmaceutical API and Intermediates Industry Trends
9.2 Pharmaceutical API and Intermediates Market Drivers
9.3 Pharmaceutical API and Intermediates Market Challenges
9.4 Pharmaceutical API and Intermediates Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
1.1 Product Definition
1.2 Pharmaceutical API and Intermediates by Type
1.2.1 Global Pharmaceutical API and Intermediates Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 API
1.2.3 Pharmaceutical Intermediates
1.3 Pharmaceutical API and Intermediates by Application
1.3.1 Global Pharmaceutical API and Intermediates Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Health Products
1.3.4 Feed
1.3.5 Food
1.3.6 Cosmetics
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pharmaceutical API and Intermediates Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pharmaceutical API and Intermediates Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pharmaceutical API and Intermediates Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical API and Intermediates Production Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical API and Intermediates Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pharmaceutical API and Intermediates, Industry Ranking, 2023 VS 2024
2.4 Global Pharmaceutical API and Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical API and Intermediates Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pharmaceutical API and Intermediates, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical API and Intermediates, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical API and Intermediates, Date of Enter into This Industry
2.9 Pharmaceutical API and Intermediates Market Competitive Situation and Trends
2.9.1 Pharmaceutical API and Intermediates Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical API and Intermediates Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical API and Intermediates Production by Region
3.1 Global Pharmaceutical API and Intermediates Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pharmaceutical API and Intermediates Production Value by Region (2020-2031)
3.2.1 Global Pharmaceutical API and Intermediates Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pharmaceutical API and Intermediates by Region (2026-2031)
3.3 Global Pharmaceutical API and Intermediates Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pharmaceutical API and Intermediates Production Volume by Region (2020-2031)
3.4.1 Global Pharmaceutical API and Intermediates Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pharmaceutical API and Intermediates by Region (2026-2031)
3.5 Global Pharmaceutical API and Intermediates Market Price Analysis by Region (2020-2025)
3.6 Global Pharmaceutical API and Intermediates Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Pharmaceutical API and Intermediates Production Value Estimates and Forecasts (2020-2031)
4 Pharmaceutical API and Intermediates Consumption by Region
4.1 Global Pharmaceutical API and Intermediates Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pharmaceutical API and Intermediates Consumption by Region (2020-2031)
4.2.1 Global Pharmaceutical API and Intermediates Consumption by Region (2020-2025)
4.2.2 Global Pharmaceutical API and Intermediates Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical API and Intermediates Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pharmaceutical API and Intermediates Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical API and Intermediates Production by Type (2020-2031)
5.1.1 Global Pharmaceutical API and Intermediates Production by Type (2020-2025)
5.1.2 Global Pharmaceutical API and Intermediates Production by Type (2026-2031)
5.1.3 Global Pharmaceutical API and Intermediates Production Market Share by Type (2020-2031)
5.2 Global Pharmaceutical API and Intermediates Production Value by Type (2020-2031)
5.2.1 Global Pharmaceutical API and Intermediates Production Value by Type (2020-2025)
5.2.2 Global Pharmaceutical API and Intermediates Production Value by Type (2026-2031)
5.2.3 Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2020-2031)
5.3 Global Pharmaceutical API and Intermediates Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pharmaceutical API and Intermediates Production by Application (2020-2031)
6.1.1 Global Pharmaceutical API and Intermediates Production by Application (2020-2025)
6.1.2 Global Pharmaceutical API and Intermediates Production by Application (2026-2031)
6.1.3 Global Pharmaceutical API and Intermediates Production Market Share by Application (2020-2031)
6.2 Global Pharmaceutical API and Intermediates Production Value by Application (2020-2031)
6.2.1 Global Pharmaceutical API and Intermediates Production Value by Application (2020-2025)
6.2.2 Global Pharmaceutical API and Intermediates Production Value by Application (2026-2031)
6.2.3 Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2020-2031)
6.3 Global Pharmaceutical API and Intermediates Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Lonza
7.1.1 Lonza Pharmaceutical API and Intermediates Company Information
7.1.2 Lonza Pharmaceutical API and Intermediates Product Portfolio
7.1.3 Lonza Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Lonza Main Business and Markets Served
7.1.5 Lonza Recent Developments/Updates
7.2 Catalent
7.2.1 Catalent Pharmaceutical API and Intermediates Company Information
7.2.2 Catalent Pharmaceutical API and Intermediates Product Portfolio
7.2.3 Catalent Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Catalent Main Business and Markets Served
7.2.5 Catalent Recent Developments/Updates
7.3 Patheon
7.3.1 Patheon Pharmaceutical API and Intermediates Company Information
7.3.2 Patheon Pharmaceutical API and Intermediates Product Portfolio
7.3.3 Patheon Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Patheon Main Business and Markets Served
7.3.5 Patheon Recent Developments/Updates
7.4 Jubilant
7.4.1 Jubilant Pharmaceutical API and Intermediates Company Information
7.4.2 Jubilant Pharmaceutical API and Intermediates Product Portfolio
7.4.3 Jubilant Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Jubilant Main Business and Markets Served
7.4.5 Jubilant Recent Developments/Updates
7.5 BASF
7.5.1 BASF Pharmaceutical API and Intermediates Company Information
7.5.2 BASF Pharmaceutical API and Intermediates Product Portfolio
7.5.3 BASF Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.5.4 BASF Main Business and Markets Served
7.5.5 BASF Recent Developments/Updates
7.6 Lianhetech
7.6.1 Lianhetech Pharmaceutical API and Intermediates Company Information
7.6.2 Lianhetech Pharmaceutical API and Intermediates Product Portfolio
7.6.3 Lianhetech Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Lianhetech Main Business and Markets Served
7.6.5 Lianhetech Recent Developments/Updates
7.7 ABA Chem
7.7.1 ABA Chem Pharmaceutical API and Intermediates Company Information
7.7.2 ABA Chem Pharmaceutical API and Intermediates Product Portfolio
7.7.3 ABA Chem Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.7.4 ABA Chem Main Business and Markets Served
7.7.5 ABA Chem Recent Developments/Updates
7.8 Granules India
7.8.1 Granules India Pharmaceutical API and Intermediates Company Information
7.8.2 Granules India Pharmaceutical API and Intermediates Product Portfolio
7.8.3 Granules India Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Granules India Main Business and Markets Served
7.8.5 Granules India Recent Developments/Updates
7.9 Porton
7.9.1 Porton Pharmaceutical API and Intermediates Company Information
7.9.2 Porton Pharmaceutical API and Intermediates Product Portfolio
7.9.3 Porton Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Porton Main Business and Markets Served
7.9.5 Porton Recent Developments/Updates
7.10 Actylis
7.10.1 Actylis Pharmaceutical API and Intermediates Company Information
7.10.2 Actylis Pharmaceutical API and Intermediates Product Portfolio
7.10.3 Actylis Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Actylis Main Business and Markets Served
7.10.5 Actylis Recent Developments/Updates
7.11 Pfizer
7.11.1 Pfizer Pharmaceutical API and Intermediates Company Information
7.11.2 Pfizer Pharmaceutical API and Intermediates Product Portfolio
7.11.3 Pfizer Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Pfizer Main Business and Markets Served
7.11.5 Pfizer Recent Developments/Updates
7.12 CordenPharma
7.12.1 CordenPharma Pharmaceutical API and Intermediates Company Information
7.12.2 CordenPharma Pharmaceutical API and Intermediates Product Portfolio
7.12.3 CordenPharma Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.12.4 CordenPharma Main Business and Markets Served
7.12.5 CordenPharma Recent Developments/Updates
7.13 Codexis
7.13.1 Codexis Pharmaceutical API and Intermediates Company Information
7.13.2 Codexis Pharmaceutical API and Intermediates Product Portfolio
7.13.3 Codexis Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Codexis Main Business and Markets Served
7.13.5 Codexis Recent Developments/Updates
7.14 Sanofi
7.14.1 Sanofi Pharmaceutical API and Intermediates Company Information
7.14.2 Sanofi Pharmaceutical API and Intermediates Product Portfolio
7.14.3 Sanofi Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Sanofi Main Business and Markets Served
7.14.5 Sanofi Recent Developments/Updates
7.15 Chiracon
7.15.1 Chiracon Pharmaceutical API and Intermediates Company Information
7.15.2 Chiracon Pharmaceutical API and Intermediates Product Portfolio
7.15.3 Chiracon Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Chiracon Main Business and Markets Served
7.15.5 Chiracon Recent Developments/Updates
7.16 Jiuzhou Pharmaceutical
7.16.1 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Company Information
7.16.2 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
7.16.3 Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Jiuzhou Pharmaceutical Main Business and Markets Served
7.16.5 Jiuzhou Pharmaceutical Recent Developments/Updates
7.17 Stanley
7.17.1 Stanley Pharmaceutical API and Intermediates Company Information
7.17.2 Stanley Pharmaceutical API and Intermediates Product Portfolio
7.17.3 Stanley Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Stanley Main Business and Markets Served
7.17.5 Stanley Recent Developments/Updates
7.18 Menohua
7.18.1 Menohua Pharmaceutical API and Intermediates Company Information
7.18.2 Menohua Pharmaceutical API and Intermediates Product Portfolio
7.18.3 Menohua Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Menohua Main Business and Markets Served
7.18.5 Menohua Recent Developments/Updates
7.19 Tianyu shares
7.19.1 Tianyu shares Pharmaceutical API and Intermediates Company Information
7.19.2 Tianyu shares Pharmaceutical API and Intermediates Product Portfolio
7.19.3 Tianyu shares Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.19.4 Tianyu shares Main Business and Markets Served
7.19.5 Tianyu shares Recent Developments/Updates
7.20 Puluo Pharmaceutical
7.20.1 Puluo Pharmaceutical Pharmaceutical API and Intermediates Company Information
7.20.2 Puluo Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
7.20.3 Puluo Pharmaceutical Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.20.4 Puluo Pharmaceutical Main Business and Markets Served
7.20.5 Puluo Pharmaceutical Recent Developments/Updates
7.21 Huahai Pharmaceutical
7.21.1 Huahai Pharmaceutical Pharmaceutical API and Intermediates Company Information
7.21.2 Huahai Pharmaceutical Pharmaceutical API and Intermediates Product Portfolio
7.21.3 Huahai Pharmaceutical Pharmaceutical API and Intermediates Production, Value, Price and Gross Margin (2020-2025)
7.21.4 Huahai Pharmaceutical Main Business and Markets Served
7.21.5 Huahai Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical API and Intermediates Industry Chain Analysis
8.2 Pharmaceutical API and Intermediates Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical API and Intermediates Production Mode & Process Analysis
8.4 Pharmaceutical API and Intermediates Sales and Marketing
8.4.1 Pharmaceutical API and Intermediates Sales Channels
8.4.2 Pharmaceutical API and Intermediates Distributors
8.5 Pharmaceutical API and Intermediates Customer Analysis
9 Pharmaceutical API and Intermediates Market Dynamics
9.1 Pharmaceutical API and Intermediates Industry Trends
9.2 Pharmaceutical API and Intermediates Market Drivers
9.3 Pharmaceutical API and Intermediates Market Challenges
9.4 Pharmaceutical API and Intermediates Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Pharmaceutical API and Intermediates Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Pharmaceutical API and Intermediates Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Pharmaceutical API and Intermediates Production Capacity (Tons) by Manufacturers in 2024
Table 4. Global Pharmaceutical API and Intermediates Production by Manufacturers (2020-2025) & (Tons)
Table 5. Global Pharmaceutical API and Intermediates Production Market Share by Manufacturers (2020-2025)
Table 6. Global Pharmaceutical API and Intermediates Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Pharmaceutical API and Intermediates Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Pharmaceutical API and Intermediates, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pharmaceutical API and Intermediates as of 2024)
Table 10. Global Market Pharmaceutical API and Intermediates Average Price by Manufacturers (US$/Ton) & (2020-2025)
Table 11. Global Key Manufacturers of Pharmaceutical API and Intermediates, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Pharmaceutical API and Intermediates, Product Offered and Application
Table 13. Global Key Manufacturers of Pharmaceutical API and Intermediates, Date of Enter into This Industry
Table 14. Global Pharmaceutical API and Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical API and Intermediates Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Pharmaceutical API and Intermediates Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Pharmaceutical API and Intermediates Production Value Market Share by Region (2020-2025)
Table 19. Global Pharmaceutical API and Intermediates Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Pharmaceutical API and Intermediates Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Pharmaceutical API and Intermediates Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Pharmaceutical API and Intermediates Production (Tons) by Region (2020-2025)
Table 23. Global Pharmaceutical API and Intermediates Production Market Share by Region (2020-2025)
Table 24. Global Pharmaceutical API and Intermediates Production (Tons) Forecast by Region (2026-2031)
Table 25. Global Pharmaceutical API and Intermediates Production Market Share Forecast by Region (2026-2031)
Table 26. Global Pharmaceutical API and Intermediates Market Average Price (US$/Ton) by Region (2020-2025)
Table 27. Global Pharmaceutical API and Intermediates Market Average Price (US$/Ton) by Region (2026-2031)
Table 28. Global Pharmaceutical API and Intermediates Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 29. Global Pharmaceutical API and Intermediates Consumption by Region (2020-2025) & (Tons)
Table 30. Global Pharmaceutical API and Intermediates Consumption Market Share by Region (2020-2025)
Table 31. Global Pharmaceutical API and Intermediates Forecasted Consumption by Region (2026-2031) & (Tons)
Table 32. Global Pharmaceutical API and Intermediates Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 34. North America Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons)
Table 35. North America Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons)
Table 36. Europe Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 37. Europe Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons)
Table 38. Europe Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons)
Table 39. Asia Pacific Pharmaceutical API and Intermediates Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 40. Asia Pacific Pharmaceutical API and Intermediates Consumption by Region (2020-2025) & (Tons)
Table 41. Asia Pacific Pharmaceutical API and Intermediates Consumption by Region (2026-2031) & (Tons)
Table 42. Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 43. Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons)
Table 44. Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons)
Table 45. Global Pharmaceutical API and Intermediates Production (Tons) by Type (2020-2025)
Table 46. Global Pharmaceutical API and Intermediates Production (Tons) by Type (2026-2031)
Table 47. Global Pharmaceutical API and Intermediates Production Market Share by Type (2020-2025)
Table 48. Global Pharmaceutical API and Intermediates Production Market Share by Type (2026-2031)
Table 49. Global Pharmaceutical API and Intermediates Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Pharmaceutical API and Intermediates Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2020-2025)
Table 52. Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2026-2031)
Table 53. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Type (2020-2025)
Table 54. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Type (2026-2031)
Table 55. Global Pharmaceutical API and Intermediates Production (Tons) by Application (2020-2025)
Table 56. Global Pharmaceutical API and Intermediates Production (Tons) by Application (2026-2031)
Table 57. Global Pharmaceutical API and Intermediates Production Market Share by Application (2020-2025)
Table 58. Global Pharmaceutical API and Intermediates Production Market Share by Application (2026-2031)
Table 59. Global Pharmaceutical API and Intermediates Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Pharmaceutical API and Intermediates Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2020-2025)
Table 62. Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2026-2031)
Table 63. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Application (2020-2025)
Table 64. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Application (2026-2031)
Table 65. Lonza Pharmaceutical API and Intermediates Company Information
Table 66. Lonza Pharmaceutical API and Intermediates Specification and Application
Table 67. Lonza Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 68. Lonza Main Business and Markets Served
Table 69. Lonza Recent Developments/Updates
Table 70. Catalent Pharmaceutical API and Intermediates Company Information
Table 71. Catalent Pharmaceutical API and Intermediates Specification and Application
Table 72. Catalent Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Catalent Main Business and Markets Served
Table 74. Catalent Recent Developments/Updates
Table 75. Patheon Pharmaceutical API and Intermediates Company Information
Table 76. Patheon Pharmaceutical API and Intermediates Specification and Application
Table 77. Patheon Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Patheon Main Business and Markets Served
Table 79. Patheon Recent Developments/Updates
Table 80. Jubilant Pharmaceutical API and Intermediates Company Information
Table 81. Jubilant Pharmaceutical API and Intermediates Specification and Application
Table 82. Jubilant Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Jubilant Main Business and Markets Served
Table 84. Jubilant Recent Developments/Updates
Table 85. BASF Pharmaceutical API and Intermediates Company Information
Table 86. BASF Pharmaceutical API and Intermediates Specification and Application
Table 87. BASF Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. BASF Main Business and Markets Served
Table 89. BASF Recent Developments/Updates
Table 90. Lianhetech Pharmaceutical API and Intermediates Company Information
Table 91. Lianhetech Pharmaceutical API and Intermediates Specification and Application
Table 92. Lianhetech Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Lianhetech Main Business and Markets Served
Table 94. Lianhetech Recent Developments/Updates
Table 95. ABA Chem Pharmaceutical API and Intermediates Company Information
Table 96. ABA Chem Pharmaceutical API and Intermediates Specification and Application
Table 97. ABA Chem Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. ABA Chem Main Business and Markets Served
Table 99. ABA Chem Recent Developments/Updates
Table 100. Granules India Pharmaceutical API and Intermediates Company Information
Table 101. Granules India Pharmaceutical API and Intermediates Specification and Application
Table 102. Granules India Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Granules India Main Business and Markets Served
Table 104. Granules India Recent Developments/Updates
Table 105. Porton Pharmaceutical API and Intermediates Company Information
Table 106. Porton Pharmaceutical API and Intermediates Specification and Application
Table 107. Porton Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Porton Main Business and Markets Served
Table 109. Porton Recent Developments/Updates
Table 110. Actylis Pharmaceutical API and Intermediates Company Information
Table 111. Actylis Pharmaceutical API and Intermediates Specification and Application
Table 112. Actylis Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Actylis Main Business and Markets Served
Table 114. Actylis Recent Developments/Updates
Table 115. Pfizer Pharmaceutical API and Intermediates Company Information
Table 116. Pfizer Pharmaceutical API and Intermediates Specification and Application
Table 117. Pfizer Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Pfizer Main Business and Markets Served
Table 119. Pfizer Recent Developments/Updates
Table 120. CordenPharma Pharmaceutical API and Intermediates Company Information
Table 121. CordenPharma Pharmaceutical API and Intermediates Specification and Application
Table 122. CordenPharma Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. CordenPharma Main Business and Markets Served
Table 124. CordenPharma Recent Developments/Updates
Table 125. Codexis Pharmaceutical API and Intermediates Company Information
Table 126. Codexis Pharmaceutical API and Intermediates Specification and Application
Table 127. Codexis Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Codexis Main Business and Markets Served
Table 129. Codexis Recent Developments/Updates
Table 130. Sanofi Pharmaceutical API and Intermediates Company Information
Table 131. Sanofi Pharmaceutical API and Intermediates Specification and Application
Table 132. Sanofi Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. Sanofi Main Business and Markets Served
Table 134. Sanofi Recent Developments/Updates
Table 135. Chiracon Pharmaceutical API and Intermediates Company Information
Table 136. Chiracon Pharmaceutical API and Intermediates Specification and Application
Table 137. Chiracon Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. Chiracon Main Business and Markets Served
Table 139. Chiracon Recent Developments/Updates
Table 140. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Company Information
Table 141. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Specification and Application
Table 142. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 143. Jiuzhou Pharmaceutical Main Business and Markets Served
Table 144. Jiuzhou Pharmaceutical Recent Developments/Updates
Table 145. Stanley Pharmaceutical API and Intermediates Company Information
Table 146. Stanley Pharmaceutical API and Intermediates Specification and Application
Table 147. Stanley Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 148. Stanley Main Business and Markets Served
Table 149. Stanley Recent Developments/Updates
Table 150. Menohua Pharmaceutical API and Intermediates Company Information
Table 151. Menohua Pharmaceutical API and Intermediates Specification and Application
Table 152. Menohua Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 153. Menohua Main Business and Markets Served
Table 154. Menohua Recent Developments/Updates
Table 155. Tianyu shares Pharmaceutical API and Intermediates Company Information
Table 156. Tianyu shares Pharmaceutical API and Intermediates Specification and Application
Table 157. Tianyu shares Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 158. Tianyu shares Main Business and Markets Served
Table 159. Tianyu shares Recent Developments/Updates
Table 160. Puluo Pharmaceutical Pharmaceutical API and Intermediates Company Information
Table 161. Puluo Pharmaceutical Pharmaceutical API and Intermediates Specification and Application
Table 162. Puluo Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 163. Puluo Pharmaceutical Main Business and Markets Served
Table 164. Puluo Pharmaceutical Recent Developments/Updates
Table 165. Huahai Pharmaceutical Pharmaceutical API and Intermediates Company Information
Table 166. Huahai Pharmaceutical Pharmaceutical API and Intermediates Specification and Application
Table 167. Huahai Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 168. Huahai Pharmaceutical Main Business and Markets Served
Table 169. Huahai Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Pharmaceutical API and Intermediates Distributors List
Table 173. Pharmaceutical API and Intermediates Customers List
Table 174. Pharmaceutical API and Intermediates Market Trends
Table 175. Pharmaceutical API and Intermediates Market Drivers
Table 176. Pharmaceutical API and Intermediates Market Challenges
Table 177. Pharmaceutical API and Intermediates Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharmaceutical API and Intermediates
Figure 2. Global Pharmaceutical API and Intermediates Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Pharmaceutical API and Intermediates Market Share by Type: 2024 VS 2031
Figure 4. API Product Picture
Figure 5. Pharmaceutical Intermediates Product Picture
Figure 6. Global Pharmaceutical API and Intermediates Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Pharmaceutical API and Intermediates Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical
Figure 9. Health Products
Figure 10. Feed
Figure 11. Food
Figure 12. Cosmetics
Figure 13. Global Pharmaceutical API and Intermediates Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pharmaceutical API and Intermediates Production Value (US$ Million) & (2020-2031)
Figure 15. Global Pharmaceutical API and Intermediates Production Capacity (Tons) & (2020-2031)
Figure 16. Global Pharmaceutical API and Intermediates Production (Tons) & (2020-2031)
Figure 17. Global Pharmaceutical API and Intermediates Average Price (US$/Ton) & (2020-2031)
Figure 18. Pharmaceutical API and Intermediates Report Years Considered
Figure 19. Pharmaceutical API and Intermediates Production Share by Manufacturers in 2024
Figure 20. Global Pharmaceutical API and Intermediates Production Value Share by Manufacturers (2024)
Figure 21. Pharmaceutical API and Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical API and Intermediates Revenue in 2024
Figure 23. Global Pharmaceutical API and Intermediates Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 24. Global Pharmaceutical API and Intermediates Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. Global Pharmaceutical API and Intermediates Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 26. Global Pharmaceutical API and Intermediates Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 27. North America Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Europe Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. China Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
Figure 30. Japan Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
Figure 31. Global Pharmaceutical API and Intermediates Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 32. Global Pharmaceutical API and Intermediates Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 33. North America Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 34. North America Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031)
Figure 35. U.S. Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 36. Canada Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 37. Europe Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 38. Europe Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031)
Figure 39. Germany Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 40. France Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 41. U.K. Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 42. Italy Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 43. Russia Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 44. Asia Pacific Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 45. Asia Pacific Pharmaceutical API and Intermediates Consumption Market Share by Region (2020-2031)
Figure 46. China Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 47. Japan Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 48. South Korea Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 49. China Taiwan Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 50. Southeast Asia Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 51. India Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 52. Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 53. Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031)
Figure 54. Mexico Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 55. Brazil Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 56. Turkey Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 57. GCC Countries Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 58. Global Production Market Share of Pharmaceutical API and Intermediates by Type (2020-2031)
Figure 59. Global Production Value Market Share of Pharmaceutical API and Intermediates by Type (2020-2031)
Figure 60. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Type (2020-2031)
Figure 61. Global Production Market Share of Pharmaceutical API and Intermediates by Application (2020-2031)
Figure 62. Global Production Value Market Share of Pharmaceutical API and Intermediates by Application (2020-2031)
Figure 63. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Application (2020-2031)
Figure 64. Pharmaceutical API and Intermediates Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Table 1. Global Pharmaceutical API and Intermediates Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Pharmaceutical API and Intermediates Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Pharmaceutical API and Intermediates Production Capacity (Tons) by Manufacturers in 2024
Table 4. Global Pharmaceutical API and Intermediates Production by Manufacturers (2020-2025) & (Tons)
Table 5. Global Pharmaceutical API and Intermediates Production Market Share by Manufacturers (2020-2025)
Table 6. Global Pharmaceutical API and Intermediates Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Pharmaceutical API and Intermediates Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Pharmaceutical API and Intermediates, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pharmaceutical API and Intermediates as of 2024)
Table 10. Global Market Pharmaceutical API and Intermediates Average Price by Manufacturers (US$/Ton) & (2020-2025)
Table 11. Global Key Manufacturers of Pharmaceutical API and Intermediates, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Pharmaceutical API and Intermediates, Product Offered and Application
Table 13. Global Key Manufacturers of Pharmaceutical API and Intermediates, Date of Enter into This Industry
Table 14. Global Pharmaceutical API and Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical API and Intermediates Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Pharmaceutical API and Intermediates Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Pharmaceutical API and Intermediates Production Value Market Share by Region (2020-2025)
Table 19. Global Pharmaceutical API and Intermediates Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Pharmaceutical API and Intermediates Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Pharmaceutical API and Intermediates Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Pharmaceutical API and Intermediates Production (Tons) by Region (2020-2025)
Table 23. Global Pharmaceutical API and Intermediates Production Market Share by Region (2020-2025)
Table 24. Global Pharmaceutical API and Intermediates Production (Tons) Forecast by Region (2026-2031)
Table 25. Global Pharmaceutical API and Intermediates Production Market Share Forecast by Region (2026-2031)
Table 26. Global Pharmaceutical API and Intermediates Market Average Price (US$/Ton) by Region (2020-2025)
Table 27. Global Pharmaceutical API and Intermediates Market Average Price (US$/Ton) by Region (2026-2031)
Table 28. Global Pharmaceutical API and Intermediates Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 29. Global Pharmaceutical API and Intermediates Consumption by Region (2020-2025) & (Tons)
Table 30. Global Pharmaceutical API and Intermediates Consumption Market Share by Region (2020-2025)
Table 31. Global Pharmaceutical API and Intermediates Forecasted Consumption by Region (2026-2031) & (Tons)
Table 32. Global Pharmaceutical API and Intermediates Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 34. North America Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons)
Table 35. North America Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons)
Table 36. Europe Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 37. Europe Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons)
Table 38. Europe Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons)
Table 39. Asia Pacific Pharmaceutical API and Intermediates Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 40. Asia Pacific Pharmaceutical API and Intermediates Consumption by Region (2020-2025) & (Tons)
Table 41. Asia Pacific Pharmaceutical API and Intermediates Consumption by Region (2026-2031) & (Tons)
Table 42. Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 43. Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2020-2025) & (Tons)
Table 44. Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption by Country (2026-2031) & (Tons)
Table 45. Global Pharmaceutical API and Intermediates Production (Tons) by Type (2020-2025)
Table 46. Global Pharmaceutical API and Intermediates Production (Tons) by Type (2026-2031)
Table 47. Global Pharmaceutical API and Intermediates Production Market Share by Type (2020-2025)
Table 48. Global Pharmaceutical API and Intermediates Production Market Share by Type (2026-2031)
Table 49. Global Pharmaceutical API and Intermediates Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Pharmaceutical API and Intermediates Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2020-2025)
Table 52. Global Pharmaceutical API and Intermediates Production Value Market Share by Type (2026-2031)
Table 53. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Type (2020-2025)
Table 54. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Type (2026-2031)
Table 55. Global Pharmaceutical API and Intermediates Production (Tons) by Application (2020-2025)
Table 56. Global Pharmaceutical API and Intermediates Production (Tons) by Application (2026-2031)
Table 57. Global Pharmaceutical API and Intermediates Production Market Share by Application (2020-2025)
Table 58. Global Pharmaceutical API and Intermediates Production Market Share by Application (2026-2031)
Table 59. Global Pharmaceutical API and Intermediates Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Pharmaceutical API and Intermediates Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2020-2025)
Table 62. Global Pharmaceutical API and Intermediates Production Value Market Share by Application (2026-2031)
Table 63. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Application (2020-2025)
Table 64. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Application (2026-2031)
Table 65. Lonza Pharmaceutical API and Intermediates Company Information
Table 66. Lonza Pharmaceutical API and Intermediates Specification and Application
Table 67. Lonza Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 68. Lonza Main Business and Markets Served
Table 69. Lonza Recent Developments/Updates
Table 70. Catalent Pharmaceutical API and Intermediates Company Information
Table 71. Catalent Pharmaceutical API and Intermediates Specification and Application
Table 72. Catalent Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Catalent Main Business and Markets Served
Table 74. Catalent Recent Developments/Updates
Table 75. Patheon Pharmaceutical API and Intermediates Company Information
Table 76. Patheon Pharmaceutical API and Intermediates Specification and Application
Table 77. Patheon Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Patheon Main Business and Markets Served
Table 79. Patheon Recent Developments/Updates
Table 80. Jubilant Pharmaceutical API and Intermediates Company Information
Table 81. Jubilant Pharmaceutical API and Intermediates Specification and Application
Table 82. Jubilant Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Jubilant Main Business and Markets Served
Table 84. Jubilant Recent Developments/Updates
Table 85. BASF Pharmaceutical API and Intermediates Company Information
Table 86. BASF Pharmaceutical API and Intermediates Specification and Application
Table 87. BASF Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. BASF Main Business and Markets Served
Table 89. BASF Recent Developments/Updates
Table 90. Lianhetech Pharmaceutical API and Intermediates Company Information
Table 91. Lianhetech Pharmaceutical API and Intermediates Specification and Application
Table 92. Lianhetech Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Lianhetech Main Business and Markets Served
Table 94. Lianhetech Recent Developments/Updates
Table 95. ABA Chem Pharmaceutical API and Intermediates Company Information
Table 96. ABA Chem Pharmaceutical API and Intermediates Specification and Application
Table 97. ABA Chem Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. ABA Chem Main Business and Markets Served
Table 99. ABA Chem Recent Developments/Updates
Table 100. Granules India Pharmaceutical API and Intermediates Company Information
Table 101. Granules India Pharmaceutical API and Intermediates Specification and Application
Table 102. Granules India Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Granules India Main Business and Markets Served
Table 104. Granules India Recent Developments/Updates
Table 105. Porton Pharmaceutical API and Intermediates Company Information
Table 106. Porton Pharmaceutical API and Intermediates Specification and Application
Table 107. Porton Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Porton Main Business and Markets Served
Table 109. Porton Recent Developments/Updates
Table 110. Actylis Pharmaceutical API and Intermediates Company Information
Table 111. Actylis Pharmaceutical API and Intermediates Specification and Application
Table 112. Actylis Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Actylis Main Business and Markets Served
Table 114. Actylis Recent Developments/Updates
Table 115. Pfizer Pharmaceutical API and Intermediates Company Information
Table 116. Pfizer Pharmaceutical API and Intermediates Specification and Application
Table 117. Pfizer Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Pfizer Main Business and Markets Served
Table 119. Pfizer Recent Developments/Updates
Table 120. CordenPharma Pharmaceutical API and Intermediates Company Information
Table 121. CordenPharma Pharmaceutical API and Intermediates Specification and Application
Table 122. CordenPharma Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. CordenPharma Main Business and Markets Served
Table 124. CordenPharma Recent Developments/Updates
Table 125. Codexis Pharmaceutical API and Intermediates Company Information
Table 126. Codexis Pharmaceutical API and Intermediates Specification and Application
Table 127. Codexis Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Codexis Main Business and Markets Served
Table 129. Codexis Recent Developments/Updates
Table 130. Sanofi Pharmaceutical API and Intermediates Company Information
Table 131. Sanofi Pharmaceutical API and Intermediates Specification and Application
Table 132. Sanofi Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. Sanofi Main Business and Markets Served
Table 134. Sanofi Recent Developments/Updates
Table 135. Chiracon Pharmaceutical API and Intermediates Company Information
Table 136. Chiracon Pharmaceutical API and Intermediates Specification and Application
Table 137. Chiracon Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. Chiracon Main Business and Markets Served
Table 139. Chiracon Recent Developments/Updates
Table 140. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Company Information
Table 141. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Specification and Application
Table 142. Jiuzhou Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 143. Jiuzhou Pharmaceutical Main Business and Markets Served
Table 144. Jiuzhou Pharmaceutical Recent Developments/Updates
Table 145. Stanley Pharmaceutical API and Intermediates Company Information
Table 146. Stanley Pharmaceutical API and Intermediates Specification and Application
Table 147. Stanley Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 148. Stanley Main Business and Markets Served
Table 149. Stanley Recent Developments/Updates
Table 150. Menohua Pharmaceutical API and Intermediates Company Information
Table 151. Menohua Pharmaceutical API and Intermediates Specification and Application
Table 152. Menohua Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 153. Menohua Main Business and Markets Served
Table 154. Menohua Recent Developments/Updates
Table 155. Tianyu shares Pharmaceutical API and Intermediates Company Information
Table 156. Tianyu shares Pharmaceutical API and Intermediates Specification and Application
Table 157. Tianyu shares Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 158. Tianyu shares Main Business and Markets Served
Table 159. Tianyu shares Recent Developments/Updates
Table 160. Puluo Pharmaceutical Pharmaceutical API and Intermediates Company Information
Table 161. Puluo Pharmaceutical Pharmaceutical API and Intermediates Specification and Application
Table 162. Puluo Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 163. Puluo Pharmaceutical Main Business and Markets Served
Table 164. Puluo Pharmaceutical Recent Developments/Updates
Table 165. Huahai Pharmaceutical Pharmaceutical API and Intermediates Company Information
Table 166. Huahai Pharmaceutical Pharmaceutical API and Intermediates Specification and Application
Table 167. Huahai Pharmaceutical Pharmaceutical API and Intermediates Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 168. Huahai Pharmaceutical Main Business and Markets Served
Table 169. Huahai Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Pharmaceutical API and Intermediates Distributors List
Table 173. Pharmaceutical API and Intermediates Customers List
Table 174. Pharmaceutical API and Intermediates Market Trends
Table 175. Pharmaceutical API and Intermediates Market Drivers
Table 176. Pharmaceutical API and Intermediates Market Challenges
Table 177. Pharmaceutical API and Intermediates Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharmaceutical API and Intermediates
Figure 2. Global Pharmaceutical API and Intermediates Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Pharmaceutical API and Intermediates Market Share by Type: 2024 VS 2031
Figure 4. API Product Picture
Figure 5. Pharmaceutical Intermediates Product Picture
Figure 6. Global Pharmaceutical API and Intermediates Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Pharmaceutical API and Intermediates Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical
Figure 9. Health Products
Figure 10. Feed
Figure 11. Food
Figure 12. Cosmetics
Figure 13. Global Pharmaceutical API and Intermediates Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pharmaceutical API and Intermediates Production Value (US$ Million) & (2020-2031)
Figure 15. Global Pharmaceutical API and Intermediates Production Capacity (Tons) & (2020-2031)
Figure 16. Global Pharmaceutical API and Intermediates Production (Tons) & (2020-2031)
Figure 17. Global Pharmaceutical API and Intermediates Average Price (US$/Ton) & (2020-2031)
Figure 18. Pharmaceutical API and Intermediates Report Years Considered
Figure 19. Pharmaceutical API and Intermediates Production Share by Manufacturers in 2024
Figure 20. Global Pharmaceutical API and Intermediates Production Value Share by Manufacturers (2024)
Figure 21. Pharmaceutical API and Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical API and Intermediates Revenue in 2024
Figure 23. Global Pharmaceutical API and Intermediates Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 24. Global Pharmaceutical API and Intermediates Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. Global Pharmaceutical API and Intermediates Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 26. Global Pharmaceutical API and Intermediates Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 27. North America Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Europe Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. China Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
Figure 30. Japan Pharmaceutical API and Intermediates Production Value (US$ Million) Growth Rate (2020-2031)
Figure 31. Global Pharmaceutical API and Intermediates Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 32. Global Pharmaceutical API and Intermediates Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 33. North America Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 34. North America Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031)
Figure 35. U.S. Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 36. Canada Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 37. Europe Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 38. Europe Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031)
Figure 39. Germany Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 40. France Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 41. U.K. Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 42. Italy Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 43. Russia Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 44. Asia Pacific Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 45. Asia Pacific Pharmaceutical API and Intermediates Consumption Market Share by Region (2020-2031)
Figure 46. China Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 47. Japan Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 48. South Korea Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 49. China Taiwan Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 50. Southeast Asia Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 51. India Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 52. Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 53. Latin America, Middle East & Africa Pharmaceutical API and Intermediates Consumption Market Share by Country (2020-2031)
Figure 54. Mexico Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 55. Brazil Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 56. Turkey Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 57. GCC Countries Pharmaceutical API and Intermediates Consumption and Growth Rate (2020-2031) & (Tons)
Figure 58. Global Production Market Share of Pharmaceutical API and Intermediates by Type (2020-2031)
Figure 59. Global Production Value Market Share of Pharmaceutical API and Intermediates by Type (2020-2031)
Figure 60. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Type (2020-2031)
Figure 61. Global Production Market Share of Pharmaceutical API and Intermediates by Application (2020-2031)
Figure 62. Global Production Value Market Share of Pharmaceutical API and Intermediates by Application (2020-2031)
Figure 63. Global Pharmaceutical API and Intermediates Price (US$/Ton) by Application (2020-2031)
Figure 64. Pharmaceutical API and Intermediates Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232